Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy

Glioblastoma (GBM) is highly invasive and the deadliest brain tumor in adults. It is characterized by inter-tumor and intra-tumor heterogeneity, short patient survival, and lack of effective treatment. Prognosis and therapy selection is driven by molecular data from gene transcription, genetic alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei, Xia, Qin, Liu, Liqun, Li, Shouwei, Dong, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506064/
https://www.ncbi.nlm.nih.gov/pubmed/33102518
http://dx.doi.org/10.3389/fmolb.2020.562798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506064/
https://www.ncbi.nlm.nih.gov/pubmed/33102518
http://dx.doi.org/10.3389/fmolb.2020.562798

Ejemplares similares